Abstract
Dover developed molecular constructs and the initial in viro data that initiated a structural biology route to the determination of the mode of action of the important anti-TB agent ethionamide used to treat multi-drug resistant infections and its analogue prothionamide used to treat leprosy.
Original language | English |
---|---|
Pages (from-to) | 73-78 |
Journal | Journal of Experimental Medicine |
Volume | 204 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2007 |